Impact of COVID-19 pandemic on central-line–associated bloodstream infections during the early months of 2020, National Healthcare Safety Network
Prachi Patel, Lindsey M. Weiner, Margaret A. Dudeck, Lucy Fike, David T. Kuhar, Jonathan R. Edwards, Daniel A. Pollock, Andrea L. Benin
Abstract
Data reported to the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC NHSN) were analyzed to understand the potential impact of the COVID-19 pandemic on central-line-associated bloodstream infections (CLABSIs) in acute-care hospitals. Descriptive analysis of the standardized infection ratio (SIR) was conducted by location, location type, geographic area, and bed size.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)MedicineCentral lineInfection controlHealth care2019-20 coronavirus outbreakDisease controlBloodstream infectionEmergency medicineAcute careSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medical emergencyIntensive care medicineDiseaseEnvironmental healthInfectious disease (medical specialty)VirologyInternal medicineEconomicsEconomic growthOutbreakCOVID-19 and healthcare impactsPatient Satisfaction in HealthcareHealthcare cost, quality, practices